Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer.
Journal: Journal for immunotherapy of cancer
Published: February 09, 2026
Preclinical and clinical evaluation of futibatinib in combination with binimetinib in patients with advanced cancer.
Journal: Investigational new drugs
Published: December 18, 2025
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity.
Journal: Clinical and translational science
Published: November 24, 2025
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 06, 2025
Biomarker study of pembrolizumab in patients with advanced rare cancers.
Journal: Cell reports. Medicine
Published: September 24, 2025
Targeting the epigenome and immune evasion: a new chapter in PRMT5 inhibition.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 15, 2025
Progress in targeting the untouchables: emerging approaches for hard-to-drug cancer targets.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 03, 2025
Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology.
Journal: Signal transduction and targeted therapy
Published: August 12, 2025
Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss-No Target Is Out of the Realm of Possibility.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 28, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit.
Journal: Cancer research communications
Published: February 04, 2025
Efficacy assessment in phase I clinical trials: endpoints and challenges.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 18, 2024
Last Updated: 09/26/2026